e-learning
resources
Barcelona 2013
Monday, 09.09.2013
Acute lung injury: novel clinical and experimental insights
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Loss of plasma phospholipid transfer protein (PLTP) activity enhances inflammatory responses to cigarette smoke in the lung
A. Brehm, P. Geraghty, I. Garcia-Arcos, J. D'Armiento, E. Eden, R. Foronjy (New York, United States Of America)
Source:
Annual Congress 2013 –Acute lung injury: novel clinical and experimental insights
Session:
Acute lung injury: novel clinical and experimental insights
Session type:
Oral Presentation
Number:
1813
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Brehm, P. Geraghty, I. Garcia-Arcos, J. D'Armiento, E. Eden, R. Foronjy (New York, United States Of America). Loss of plasma phospholipid transfer protein (PLTP) activity enhances inflammatory responses to cigarette smoke in the lung. Eur Respir J 2013; 42: Suppl. 57, 1813
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Cigarette smoke impairs Sirt1 activity and promotes pro-inflammatory responses in bronchial epithelial cells
Source: International Congress 2015 – Immunomodulation: basic science and clinical aspects
Year: 2015
Cigarette smoke extract induces the release of extracellular vesicles by airway epithelial cells via cellular carbonyl stress
Source: International Congress 2015 – Immunomodulation: basic science and clinical aspects
Year: 2015
Cigarette smoke impairs autophagic flux in bronchial epithelial cells
Source: Annual Congress 2013 –Stress responses and T-cell behaviour in the lung
Year: 2013
cPLA2alpha plays a role in neutrophilic inflammatory response in mice induced by tobacco smoke exposure
Source: Annual Congress 2013 –Novel in vitro and animal models to study lung diseases
Year: 2013
Ceramide-1-phosphate attenuates cigarette smoke induce lung inflammation
Source: Annual Congress 2013 –Cell biology and murine models of asthma and inflammation
Year: 2013
NDP52 inhibition rescues cigarette smoke mediated impairment of autophagy in macrophages
Source: International Congress 2016 – New therapies and therapeutic targets
Year: 2016
Steroid resistance in COPD is associated with impaired molecular chaperone HSP90 expression by pro-inflammatory lymphocytes
Source: International Congress 2016 – Mechanisms of disease
Year: 2016
Altered scavenger receptor expression and response to oxidative stress is linked to defective bacterial phagocytosis in COPD macrophages
Source: International Congress 2016 – Mechanisms of disease
Year: 2016
Quercetin attenuates inflammation in cigarette smoke stimulated airway epithelial cells: Possible involvement of autophagy
Source: Annual Congress 2013 –New drugs in respiratory medicine
Year: 2013
Tobacco smoke causes release of IL-16 protein from NK cells in vitro
Source: International Congress 2015 – Immunomodulation: basic science and clinical aspects
Year: 2015
The AMPK-TSC1/2-mTOR signaling pathway regulates cigarette smoking-induced inflammation and apoptosis in airway epithelial cells
Source: International Congress 2015 – Molecular pathways of lung injury due to tobacco-related products
Year: 2015
IL-17A is elevated in patients with COPD and contributes to airway remodeling by acting on fibroblasts
Source: International Congress 2016 – What's new in biomarker analysis?
Year: 2016
Recurrent cigarette smoke exposure impairs SIRT1 shuttling in bronchial epithelial cells
Source: International Congress 2016 – Translational studies in lung disease
Year: 2016
Role of chronic exposure to cigarette smoke on endoglin/CD105 expression in airway epithelium
Source: International Congress 2015 – Cellular and molecular mechanisms of COPD and emphysema
Year: 2015
Inhibition of lung inflammation by a protein epitope mimetic (PEM) neutrophil elastase inhibitor, POL6014, in a sub-chronic tobacco smoke (TS) model in mice
Source: Annual Congress 2013 –Novel drugs for the treatment of asthma and COPD
Year: 2013
Cigarette smoke inhibits lung fibroblast proliferation by translational mechanisms
Source: Eur Respir J 2012; 39: 705-711
Year: 2012
Enhanced neutrophil extracellular trap (NET) formation in sputum of stable COPD patients
Source: International Congress 2015 – Mucosal immunology: what’s new in 2015
Year: 2015
Aberrant airway epithelial differentiation resulting from cigarette smoke exposure leads to loss of constitutive antimicrobial peptide and protein (AMP) expression
Source: International Congress 2016 – New findings in mucosal immunology
Year: 2016
Carbocysteine restores the expression and the activation of TLR4 altered by cigarette smoke extracts in bronchial epithelial cells
Source: Annual Congress 2013 –Molecular biology: state-of-the-art 2013
Year: 2013
Inflammatory-cellular composition of the induced sputum (IS) and activity of leucocytes myeloperoxidase (MPO) in asthmatics with different airway response to hyperosmolar stimulus
Source: International Congress 2016 – What's new in biomarker analysis?
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept